Annual CFO:
-$128.41M+$16.67M(+11.49%)Summary
- As of today, AXSM annual cash from operations is -$128.41 million, with the most recent change of +$16.67 million (+11.49%) on December 31, 2024.
- During the last 3 years, AXSM annual cash from operations has fallen by -$20.18 million (-18.65%).
- AXSM annual cash from operations is now -7772.60% below its all-time high of -$1.63 million, reached on December 31, 2013.
Performance
AXSM Cash From Operations Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly CFO:
-$32.42M+$10.95M(+25.25%)Summary
- As of today, AXSM quarterly cash from operations is -$32.42 million, with the most recent change of +$10.95 million (+25.25%) on June 30, 2025.
- Over the past year, AXSM quarterly cash from operations has dropped by -$2.31 million (-7.68%).
- AXSM quarterly cash from operations is now -2697.74% below its all-time high of -$1.16 million, reached on March 31, 2015.
Performance
AXSM Quarterly Cash From Operations Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM CFO:
-$120.63M-$2.31M(-1.95%)Summary
- As of today, AXSM TTM cash from operations is -$120.63 million, with the most recent change of -$2.31 million (-1.95%) on June 30, 2025.
- Over the past year, AXSM TTM cash from operations has increased by +$46.86 million (+27.98%).
- AXSM TTM cash from operations is now -10309.09% below its all-time high of -$1.16 million, reached on March 31, 2015.
Performance
AXSM TTM Cash From Operations Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Cash From Operations Formula
CFO = Net Income + Non Cash Expenses + Changes In Working Capital
AXSM Cash From Operations Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1Y1 Year | +11.5% | -7.7% | +28.0% |
| 3Y3 Years | -18.6% | +3.3% | +1.2% |
| 5Y5 Years | -176.9% | -71.6% | -59.8% |
AXSM Cash From Operations Highs & Lows
| PeriodPeriod | Annual vs HighAnnual vs High | Annual vs LowAnnual vs Low | Quarter. vs HighQuarter. vs High | Quarter. vs LowQuarter. vs Low | TTM vs HighTTM vs High | TTM vs LowTTM vs Low | |
|---|---|---|---|---|---|---|---|
| 3Y | 3-Year | -18.6% | +11.5% | -457.0% | +41.4% | -34.5% | +37.4% |
| 5Y | 5-Year | -176.9% | +11.5% | -457.0% | +41.4% | -59.8% | +37.4% |
| All-Time | All-Time | -7772.6% | +11.5% | -2697.7% | +41.4% | >-9999.0% | +37.4% |
AXSM Cash From Operations History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2025 | - | -$32.42M(+25.2%) | -$120.63M(-2.0%) |
| Mar 2025 | - | -$43.38M(-65.5%) | -$118.32M(+7.9%) |
| Dec 2024 | -$128.41M(+11.5%) | -$26.20M(-40.6%) | -$128.41M(+3.1%) |
| Sep 2024 | - | -$18.63M(+38.1%) | -$132.57M(+20.8%) |
| Jun 2024 | - | -$30.11M(+43.7%) | -$167.49M(+13.1%) |
| Mar 2024 | - | -$53.47M(-76.1%) | -$192.73M(-32.8%) |
| Dec 2023 | -$145.08M(-24.5%) | -$30.36M(+43.3%) | -$145.08M(-2.0%) |
| Sep 2023 | - | -$53.55M(+3.3%) | -$142.28M(-27.6%) |
| Jun 2023 | - | -$55.35M(-850.9%) | -$111.49M(-24.3%) |
| Mar 2023 | - | -$5.82M(+78.9%) | -$89.68M(+23.0%) |
| Dec 2022 | -$116.51M(-7.7%) | -$27.56M(-21.1%) | -$116.51M(+1.3%) |
| Sep 2022 | - | -$22.76M(+32.1%) | -$118.10M(+3.3%) |
| Jun 2022 | - | -$33.54M(-2.7%) | -$122.12M(-7.1%) |
| Mar 2022 | - | -$32.65M(-12.0%) | -$113.97M(-5.0%) |
| Dec 2021 | -$108.23M(-37.9%) | -$29.15M(-8.9%) | -$108.54M(-8.6%) |
| Sep 2021 | - | -$26.78M(-5.4%) | -$99.94M(-12.4%) |
| Jun 2021 | - | -$25.39M(+6.7%) | -$88.90M(-7.9%) |
| Mar 2021 | - | -$27.22M(-32.4%) | -$82.40M(-5.0%) |
| Dec 2020 | -$78.46M(-69.2%) | -$20.55M(-30.6%) | -$78.46M(-4.0%) |
| Sep 2020 | - | -$15.73M(+16.7%) | -$75.47M(-7.3%) |
| Jun 2020 | - | -$18.90M(+18.8%) | -$70.36M(-17.0%) |
| Mar 2020 | - | -$23.27M(-32.5%) | -$60.15M(-29.7%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2019 | -$46.38M(-54.3%) | -$17.57M(-65.3%) | -$46.38M(-20.1%) |
| Sep 2019 | - | -$10.63M(-22.4%) | -$38.60M(-13.9%) |
| Jun 2019 | - | -$8.68M(+8.6%) | -$33.89M(-3.1%) |
| Mar 2019 | - | -$9.50M(+3.0%) | -$32.87M(-9.4%) |
| Dec 2018 | -$30.05M(-13.5%) | -$9.79M(-65.7%) | -$30.05M(-13.2%) |
| Sep 2018 | - | -$5.91M(+22.9%) | -$26.55M(+2.0%) |
| Jun 2018 | - | -$7.67M(-14.8%) | -$27.09M(-2.2%) |
| Mar 2018 | - | -$6.68M(-6.2%) | -$26.52M(-0.2%) |
| Dec 2017 | -$26.47M(-24.4%) | -$6.29M(+2.4%) | -$26.47M(+3.4%) |
| Sep 2017 | - | -$6.45M(+9.1%) | -$27.40M(-6.4%) |
| Jun 2017 | - | -$7.10M(-6.9%) | -$25.75M(-7.4%) |
| Mar 2017 | - | -$6.64M(+8.0%) | -$23.97M(-12.6%) |
| Dec 2016 | -$21.28M(-186.1%) | -$7.22M(-50.3%) | -$21.28M(-30.4%) |
| Sep 2016 | - | -$4.80M(+9.6%) | -$16.32M(-21.4%) |
| Jun 2016 | - | -$5.31M(-34.6%) | -$13.44M(-31.4%) |
| Mar 2016 | - | -$3.95M(-75.4%) | -$10.23M(-37.5%) |
| Dec 2015 | -$7.44M(-61.8%) | -$2.25M(-17.1%) | -$7.44M(-43.4%) |
| Sep 2015 | - | -$1.92M(+8.7%) | -$5.19M(-58.9%) |
| Jun 2015 | - | -$2.11M(-81.8%) | -$3.27M(-181.8%) |
| Mar 2015 | - | -$1.16M | -$1.16M |
| Dec 2014 | -$4.60M(-181.8%) | - | - |
| Dec 2013 | -$1.63M | - | - |
FAQ
- What is Axsome Therapeutics, Inc. annual cash from operations?
- What is the all-time high annual cash from operations for Axsome Therapeutics, Inc.?
- What is Axsome Therapeutics, Inc. annual cash from operations year-on-year change?
- What is Axsome Therapeutics, Inc. quarterly cash from operations?
- What is the all-time high quarterly cash from operations for Axsome Therapeutics, Inc.?
- What is Axsome Therapeutics, Inc. quarterly cash from operations year-on-year change?
- What is Axsome Therapeutics, Inc. TTM cash from operations?
- What is the all-time high TTM cash from operations for Axsome Therapeutics, Inc.?
- What is Axsome Therapeutics, Inc. TTM cash from operations year-on-year change?
What is Axsome Therapeutics, Inc. annual cash from operations?
The current annual cash from operations of AXSM is -$128.41M
What is the all-time high annual cash from operations for Axsome Therapeutics, Inc.?
Axsome Therapeutics, Inc. all-time high annual cash from operations is -$1.63M
What is Axsome Therapeutics, Inc. annual cash from operations year-on-year change?
Over the past year, AXSM annual cash from operations has changed by +$16.67M (+11.49%)
What is Axsome Therapeutics, Inc. quarterly cash from operations?
The current quarterly cash from operations of AXSM is -$32.42M
What is the all-time high quarterly cash from operations for Axsome Therapeutics, Inc.?
Axsome Therapeutics, Inc. all-time high quarterly cash from operations is -$1.16M
What is Axsome Therapeutics, Inc. quarterly cash from operations year-on-year change?
Over the past year, AXSM quarterly cash from operations has changed by -$2.31M (-7.68%)
What is Axsome Therapeutics, Inc. TTM cash from operations?
The current TTM cash from operations of AXSM is -$120.63M
What is the all-time high TTM cash from operations for Axsome Therapeutics, Inc.?
Axsome Therapeutics, Inc. all-time high TTM cash from operations is -$1.16M
What is Axsome Therapeutics, Inc. TTM cash from operations year-on-year change?
Over the past year, AXSM TTM cash from operations has changed by +$46.86M (+27.98%)